wow! I don’t even understand that last post. Maybe you will now go away now that you feel so superior to me. I will not post here anymore it is pointless. They should only allow people over 18 to post not kids like this.
Buy out
- Thread starter anonymous
- Start date
-
- Tags
- None
Farewell Green Goddess may Gaia bless those tiny toes of yours...
Daiichi Sankyo, said to have spurned an AstraZeneca bid, says it's 'not the fact'
by Carly Helfand |
Aug 31, 2017 11:14am
Did Daiichi Sankyo receive a buyout bid from AstraZeneca last year? According to the Japanese drugmaker, no.
In response to a story from Japanese publication Nikkei Business, which claimed Daiichi had turned away an AZ acquisition bid, Daiichi released a short statement on Thursday saying, "this is not the fact." It's still unclear, however, whether the two companies discussed a deal more informally.
No clarification was forthcoming from AstraZeneca. "We have nothing to share as we don’t comment on rumors or speculation," a spokeswoman said via email.
Before Daiichi's rebuttal, Nikkei's report sent shares skyward by as much as 13% and triggered a trading halt on the Nikkei exchange.
Fake news and you're about 6 months too late. Get your head in the game. Come on man.
Daiichi Sankyo, said to have spurned an AstraZeneca bid, says it's 'not the fact'
by Carly Helfand |
Aug 31, 2017 11:14am
Did Daiichi Sankyo receive a buyout bid from AstraZeneca last year? According to the Japanese drugmaker, no.
In response to a story from Japanese publication Nikkei Business, which claimed Daiichi had turned away an AZ acquisition bid, Daiichi released a short statement on Thursday saying, "this is not the fact." It's still unclear, however, whether the two companies discussed a deal more informally.
No clarification was forthcoming from AstraZeneca. "We have nothing to share as we don’t comment on rumors or speculation," a spokeswoman said via email.
Before Daiichi's rebuttal, Nikkei's report sent shares skyward by as much as 13% and triggered a trading halt on the Nikkei exchange.
Boy that neal family will do anything to try to stir up crap... old news boys old news
QUOTE="anonymous, post: 5996848"]
Daiichi Sankyo, said to have spurned an AstraZeneca bid, says it's 'not the fact'
by Carly Helfand |
Aug 31, 2017 11:14am
Did Daiichi Sankyo receive a buyout bid from AstraZeneca last year? According to the Japanese drugmaker, no.
In response to a story from Japanese publication Nikkei Business, which claimed Daiichi had turned away an AZ acquisition bid, Daiichi released a short statement on Thursday saying, "this is not the fact." It's still unclear, however, whether the two companies discussed a deal more informally.
No clarification was forthcoming from AstraZeneca. "We have nothing to share as we don’t comment on rumors or speculation," a spokeswoman said via email.
Before Daiichi's rebuttal, Nikkei's report sent shares skyward by as much as 13% and triggered a trading halt on the Nikkei exchange.[/QUOTE]
QUOTE="anonymous, post: 5996848"]
Daiichi Sankyo, said to have spurned an AstraZeneca bid, says it's 'not the fact'
by Carly Helfand |
Aug 31, 2017 11:14am
Did Daiichi Sankyo receive a buyout bid from AstraZeneca last year? According to the Japanese drugmaker, no.
In response to a story from Japanese publication Nikkei Business, which claimed Daiichi had turned away an AZ acquisition bid, Daiichi released a short statement on Thursday saying, "this is not the fact." It's still unclear, however, whether the two companies discussed a deal more informally.
No clarification was forthcoming from AstraZeneca. "We have nothing to share as we don’t comment on rumors or speculation," a spokeswoman said via email.
Before Daiichi's rebuttal, Nikkei's report sent shares skyward by as much as 13% and triggered a trading halt on the Nikkei exchange.[/QUOTE]
Just offering a perspective. Oh and the cat is on a pink pillow......Have a nice day 
Idiot.Just offering a perspective. Oh and the cat is on a pink pillow......Have a nice day
a bid? Who gives a shit. We could bid on them. Just like Our leadership bids on reps